首页 | 本学科首页   官方微博 | 高级检索  
     

抗菌肽药物工程化技术研究进展
引用本文:汪小杰,毛若雨,王秀敏,滕达,王建华. 抗菌肽药物工程化技术研究进展[J]. 微生物学通报, 2014, 41(10): 2128-2133
作者姓名:汪小杰  毛若雨  王秀敏  滕达  王建华
作者单位:中国农业科学院饲料研究所基因工程室 农业部饲料生物技术重点开放实验室 北京 100081;中国农业科学院饲料研究所基因工程室 农业部饲料生物技术重点开放实验室 北京 100081;中国农业科学院饲料研究所基因工程室 农业部饲料生物技术重点开放实验室 北京 100081;中国农业科学院饲料研究所基因工程室 农业部饲料生物技术重点开放实验室 北京 100081;中国农业科学院饲料研究所基因工程室 农业部饲料生物技术重点开放实验室 北京 100081
基金项目:国家自然科学基金项目(No. 31372346,31302004,30972125);科技支撑计划项目(No. 2013BAD10B02,2011BAD26B02);中国农业科学院农业科技创新工程抗菌肽及“抗生素替代品方向”(2013-2017)
摘    要:尽管抗生素在畜牧业疾病防治中的主导地位在短期内不会动摇,但病原菌耐药性形成与快速发展让抗菌肽成为近年新药研发热点之一。作为一种在生物体内广泛存在的天然免疫物质,抗菌肽具有抗菌、抗病毒、抗肿瘤和免疫调节等功能,由于药效短、对蛋白酶敏感、细胞毒性高等缺陷而限制其应用。本文综述了抗菌肽基因工程技术、聚乙二醇(PEG)化、靶向性改造和固定化等工程技术在抗菌肽新药开发中的应用研究进展,以促进抗菌肽产业化。

关 键 词:抗菌肽  基因工程  聚乙二醇化  靶向性  固定化

Advances on antimicrobial peptide engineering
WANG Xiao-Jie,MAO Ruo-Yu,WANG Xiu-Min,TENG Da and WANG Jian-Hua. Advances on antimicrobial peptide engineering[J]. Microbiology China, 2014, 41(10): 2128-2133
Authors:WANG Xiao-Jie  MAO Ruo-Yu  WANG Xiu-Min  TENG Da  WANG Jian-Hua
Affiliation:Key Laboratory of Feed Biotechnology of MOA, Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China;Key Laboratory of Feed Biotechnology of MOA, Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China;Key Laboratory of Feed Biotechnology of MOA, Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China;Key Laboratory of Feed Biotechnology of MOA, Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China;Key Laboratory of Feed Biotechnology of MOA, Gene Engineering Laboratory, Feed Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China
Abstract:Although antibiotics hold a leading position in the medical treatment and animal husbandry, but its prone-resistance to the pathogen lead to the rise of research and development of antimicrobial peptides (AMPs). As natural active substances, AMPs have antibacterial, antiviral, anti-tumor and immune regulation function, while the shortcomings such as short efficacy, sensitive to proteinase and high cytotoxicity limit its application. In this paper, the bottlenecks and their solution of antimicrobial peptide engineering were reviewed in terms of gene engineering, PEGylation, targeting and immobilization in order to promote the industrialization of AMPs.
Keywords:Antimicrobial peptides   Gene engineering   PEGylation   Targeting   Immobilization
本文献已被 CNKI 等数据库收录!
点击此处可从《微生物学通报》浏览原始摘要信息
点击此处可从《微生物学通报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号